ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.

Karo Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.